Pfizer’s JAK/TEC inhibitor Litfulo has been recommended for NHS use as a treatment for hair loss caused by severe alopecia areata, the first drug therapy for a condition that affects around ...

The approval is based on the phase 2b/3 ALLEGRO trial in 718 patients with 50% or greater hair loss on the scalp, in which 23% of those treated with Litfulo reached the objective of 80% hair ...

Since then, Tisdale — who has partnered with Pfizer and Litfulo, an FDA-approved pill ... that she has "started to be way nicer to my hair and my scalp." "I used to play with a lot of colors ...

A medicine for severe hair loss, or alopecia, is being recommended on the NHS for the first time. The daily pill, called ritlecitinib or Litfulo, could help up to 14,000 people in England ...

The daily pill has been approved by drug body NICE for hair loss caused by autoimmune disease. Called Ritlecitinib or Litfulo, it could help thousands of people dealing with severe hair loss or ...